IBB iShares Nasdaq Biotechnolog...


$ 154.39 $ -2.11 (-1.35 %)    

Wednesday, 22-Oct-2025 18:08:18 EDT
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 153.92
$ 155.73
$ 153.03 x 10
$ 157.19 x 5
$ 153.25 - $ 156.37
$ 107.37 - $ 157.19
1,239,744
na
na
$ 0.85
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

 enpro-moves-to-boost-profits-with-280-million-acquisition-push

Enpro Inc. (NYSE: NPO) acquiring AlpHa Measurement Solutions and Overlook Industries for $280 million in cash.

 how-trumps-shutdown-standoff-could-hand-health-care-etfs-a-lifeline

Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' rada...

 scisparc-and-automax-call-off-merger

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

 trumps-biotech-playbook-ignites-350-billion-investment-blitz

Trump's policies have sparked a $350B investment surge in US biotech, creating job & revenue opportunities. Investors c...

 novavax-scores-key-fda-win-shares-jump-19-as-sanofi-unlocks-milestone-payment

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial dist...

 trump-orders-fda-to-fast-track-us-drug-production-as-tariff-threat-looms-on-imported-medicines-cites-national-security-concerns

President Donald Trump signed an executive order Monday directing the FDA to accelerate approvals for domestic pharmaceutical m...

 rfk-jrs-massive-federal-health-workforce-cut-could-take-decades-to-rebuild-warn-experts-we-cannot-accurately-assess-whether-we-are-truly-making-america-healthier

Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers,...

 nih-funding-cuts-to-spook-healthcare-stocks-rfk-jrs-confirmation-at-hhs-sparks-concerns-over-research-dollars-causing-uncertainty-says-analyst

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Core News & Articles

-Reuters

 avadel-pharmaceuticals-misses-earnings-estimates-but-posts-150-sales-increase-from--narcolepsy-drug-lumryz

Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose ...

 cameco-applied-digital-west-pharmaceutical-and-more-on-cnbcs-final-trades

On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation.

Core News & Articles

- SEC Filing

 top-performing-industry-etfs-in-june-software-leads-returns-chipmakers-attract-most-inflows

June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while ut...

 stocks-stall-as-chip-sector-struggles-to-rebound-dollar-eyes-7-week-peak-gold-bitcoin-retreat-whats-driving-markets-friday

Wall Street is experiencing a subdued and low volatility trading day Friday, despite the session coinciding with the “triple wi...

 april-showers-on-wall-street--miners-utilities-emerge-as-bright-spots-in-gloomy-market

Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap a...

 ai-biotech-energy-sectors-expect-ma-revival-for-2024

The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-...

 us-stocks-eye-3-day-slump-tech-crypto-sell-off-deepens-oil-dollar-rebound-whats-driving-markets-wednesday

The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION